We are attending AASLD The Liver Meeting® 2026 in Denver, CO

Subgroup definition and monitoring of liver fibrosis evolution in patients with MASH bridging fibrosis based on objective measurements of septa parameters using digital pathology with artificial intelligence analyses

-THU_445_EASL2025